Commerzbank Aktiengesellschaft FI boosted its position in shares of Exelon Co. (NASDAQ:EXC – Free Report) by 10.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 55,862 shares of the company’s stock after buying an additional 5,114 shares during the period. Commerzbank Aktiengesellschaft FI’s holdings in Exelon were worth $2,103,000 at the end of the most recent quarter.
Other hedge funds have also made changes to their positions in the company. JPMorgan Chase & Co. increased its position in shares of Exelon by 109.0% during the third quarter. JPMorgan Chase & Co. now owns 5,884,282 shares of the company’s stock worth $238,608,000 after purchasing an additional 3,068,309 shares in the last quarter. State Street Corp grew its holdings in shares of Exelon by 3.7% during the third quarter. State Street Corp now owns 60,169,219 shares of the company’s stock worth $2,439,862,000 after buying an additional 2,156,259 shares in the last quarter. Nordea Investment Management AB grew its holdings in shares of Exelon by 418.1% during the fourth quarter. Nordea Investment Management AB now owns 2,501,392 shares of the company’s stock worth $94,152,000 after buying an additional 2,018,604 shares in the last quarter. FMR LLC raised its position in shares of Exelon by 18.7% in the third quarter. FMR LLC now owns 11,782,549 shares of the company’s stock valued at $477,782,000 after buying an additional 1,858,502 shares during the last quarter. Finally, Assenagon Asset Management S.A. lifted its stake in shares of Exelon by 212.2% in the fourth quarter. Assenagon Asset Management S.A. now owns 1,903,482 shares of the company’s stock worth $71,647,000 after buying an additional 1,293,753 shares in the last quarter. Institutional investors and hedge funds own 80.92% of the company’s stock.
Exelon Stock Performance
Shares of Exelon stock opened at $44.55 on Tuesday. The firm has a market cap of $44.78 billion, a PE ratio of 18.18, a price-to-earnings-growth ratio of 2.86 and a beta of 0.56. The company has a quick ratio of 0.78, a current ratio of 0.87 and a debt-to-equity ratio of 1.61. Exelon Co. has a 52 week low of $34.01 and a 52 week high of $44.62. The business’s fifty day simple moving average is $40.28 and its 200-day simple moving average is $39.40.
Exelon Increases Dividend
The business also recently announced a quarterly dividend, which will be paid on Friday, March 14th. Investors of record on Monday, February 24th will be issued a $0.40 dividend. This represents a $1.60 annualized dividend and a yield of 3.59%. The ex-dividend date of this dividend is Monday, February 24th. This is an increase from Exelon’s previous quarterly dividend of $0.38. Exelon’s dividend payout ratio (DPR) is 65.31%.
Insider Buying and Selling at Exelon
In other Exelon news, EVP Colette D. Honorable sold 1,463 shares of Exelon stock in a transaction dated Monday, February 3rd. The stock was sold at an average price of $40.57, for a total value of $59,353.91. Following the completion of the transaction, the executive vice president now directly owns 2,271 shares of the company’s stock, valued at $92,134.47. The trade was a 39.18 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 0.10% of the stock is owned by corporate insiders.
Analyst Ratings Changes
EXC has been the subject of a number of recent research reports. BMO Capital Markets reiterated an “outperform” rating on shares of Exelon in a report on Tuesday, February 4th. Guggenheim raised Exelon from a “neutral” rating to a “buy” rating in a report on Thursday, January 23rd. Evercore ISI upgraded Exelon from an “in-line” rating to an “outperform” rating and lifted their price objective for the stock from $43.00 to $44.00 in a research report on Tuesday, January 21st. Barclays upped their target price on Exelon from $42.00 to $48.00 and gave the company an “overweight” rating in a report on Tuesday, February 25th. Finally, Morgan Stanley reduced their price target on Exelon from $46.00 to $44.00 and set an “equal weight” rating on the stock in a report on Friday, November 22nd. Five equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $44.13.
Check Out Our Latest Analysis on EXC
Exelon Profile
Exelon Corporation, a utility services holding company, engages in the energy distribution and transmission businesses in the United States and Canada. The company is involved in the purchase and regulated retail sale of electricity and natural gas, transmission and distribution of electricity, and distribution of natural gas to retail customers.
Recommended Stories
- Five stocks we like better than Exelon
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Bearish Investors Can Seek Refuge in Recession-Resistant ETFs
- 3 Healthcare Dividend Stocks to Buy
- 3 Oversold Magnificent Seven Stocks at Key Levels: Buy Now?
- 3 REITs to Buy and Hold for the Long Term
- 3M to Hit $175 by Mid-Year, and Higher Highs Are Likely
Receive News & Ratings for Exelon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exelon and related companies with MarketBeat.com's FREE daily email newsletter.